Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_assertion description "[In vivo, EGFR signaling is hyperactive in tumor cells of skin SCC but not of BCC, and in nearby asymptomatic epidermis of both tumor types/is due to upregulation of EGFR ligands AREG, HBEGF and TGFA, and downregulation of BTC ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_assertion evidence source_evidence_literature NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_assertion SIO_000772 17525275 NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_assertion wasDerivedFrom lhgdn-20090331 NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_assertion wasGeneratedBy ECO_0000203 NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP142947.RAH4AthXcO8ZnVs1CK08jzjjAf5dWlAtDxHXuqnMpDu-U130_provenance.